Thrivent Financial for Lutherans
TNDM icon

Thrivent Financial for Lutherans’s Tandem Diabetes Care TNDM Stock Holding History

Thrivent Financial for Lutherans’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$679K Sell
45,001
-255
-0.6% -$4.45K ﹤0.01% 2184
2026
Q1 		$868K Sell
45,256
-1,333
-3% -$29K ﹤0.01% 1972
2025
Q4 		$1.02M Sell
46,589
-2,157
-4% -$38.9K ﹤0.01% 1921
2025
Q3 		$592K Sell
48,746
-231
-0.5% -$3.13K ﹤0.01% 2022
2025
Q2 		$913K Buy
48,977
+736
+2% +$14.6K ﹤0.01% 1836
2025
Q1 		$924K Sell
48,241
-2,524
-5% -$73.9K ﹤0.01% 1766
2024
Q4 		$1.83M Sell
50,765
-644
-1% -$21.8K ﹤0.01% 1496
2024
Q3 		$2.18M Sell
51,409
-2,210
-4% -$93.7K ﹤0.01% 1380
2024
Q2 		$2.16M Sell
53,619
-2,952
-5% -$123K ﹤0.01% 1329
2024
Q1 		$2M Sell
56,571
-1,419
-2% -$38K ﹤0.01% 1417
2023
Q4 		$1.72M Sell
57,990
-1,543
-3% -$32K ﹤0.01% 1494
2023
Q3 		$1.24M Sell
59,533
-2,286
-4% -$62.8K ﹤0.01% 1606
2023
Q2 		$1.52M Sell
61,819
-1,902
-3% -$61.2K ﹤0.01% 1535
2023
Q1 		$2.59M Buy
63,721
+46,594
+272% +$1.93M 0.01% 1126
2022
Q4 		$770K Sell
17,127
-45,016
-72% -$2.04M ﹤0.01% 1898
2022
Q3 		$2.97M Buy
62,143
+14,977
+32% +$821K 0.01% 998
2022
Q2 		$2.79M Buy
47,166
+6,475
+16% +$532K 0.01% 1051
2022
Q1 		$4.73M Buy
40,691
+23,939
+143% +$2.79M 0.01% 911
2021
Q4 		$2.52M Sell
16,752
-2,535
-13% -$342K ﹤0.01% 1237
2021
Q3 		$2.3M Buy
+19,287
New +$2.13M ﹤0.01% 1258

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Thrivent Financial for Lutherans's TNDM Position: Q2 2026 in Review

Thrivent Financial for Lutherans reduced its Tandem Diabetes Care (TNDM) stake by 0.56% in Q2 2026, selling an estimated $4.45K and leaving 45,001 shares worth $679K. The position accounts for ﹤0.01% of the portfolio, ranked #2184.

Thrivent Financial for Lutherans first reported a position in TNDM in Q3 2021 and has held it in 20 quarters since. The position peaked at $4.73M in Q1 2022. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Thrivent Financial for Lutherans held 45,001 shares of Tandem Diabetes Care worth $679K as of Q2 2026.
  • Thrivent Financial for Lutherans sold 255 Tandem Diabetes Care shares in Q2 2026, an estimated $4.45K.
  • Tandem Diabetes Care made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #2184 holding.
  • Thrivent Financial for Lutherans first reported a position in Tandem Diabetes Care in Q3 2021 and has held it in 20 quarters since.
  • Thrivent Financial for Lutherans's Tandem Diabetes Care position peaked at $4.73M in Q1 2022.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.